Journal of Diabetes and Its Complications

Article	Citations
COVID-19 in people living with diabetes: An international consensus	97
COVID-19 and diabetes: The why, the what and the how	93
Molecular complexities underlying the vascular complications of diabetes mellitus – A comprehensive review	85
Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL/6J mice	78
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study	76
Impact of obesity on COVID-19 patients	71
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?	58
Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes	55
Role of ceramides in the pathogenesis of diabetes mellitus and its complications	52
Sex difference in the association between surrogate markers of insulin resistance and arterial stiffness	45
Homocysteine and diabetes: Role in macrovascular and microvascular complications	44
Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life	41
Glycemic control and diabetic foot ulcer outcomes: A systematic review and meta-analysis of observational studies	40
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes	40
Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review	37
Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity	34
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes	33
Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy	32
Role of ketogenic starvation sensors in mediating the renal protective effects of SGLT2 inhibitors in type 2 diabetes	29
Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP	28
Correction of anemia by dapagliflozin in patients with type 2 diabetes	28
Post-COVID syndrome, inflammation, and diabetes	28
Patient perspectives on the physical, psycho-social, and financial impacts of diabetic foot ulceration and amputation	28
Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications	27
Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes	25

Glycated albumin as biomarker: Evidence and its outcomes	25
Management of mitochondrial diabetes in the era of novel therapies	25
From obesity to Alzheimer's disease through insulin resistance	25
Fish oil reduces subclinical inflammation, insulin resistance, and atherogenic factors in overweight/obese type 2 diabetes mellitus patients: A pre-post pilot study	25
Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria – A double blind randomized placebo-controlled crossover trial	24
Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes	24
Depression and cardiovascular disease events among patients with type 2 diabetes: A systematic review and meta-analysis with bias analysis	24
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases	24
A systematic review with meta-analysis of the impact of access and quality of diabetic foot care delivery in preventing lower extremity amputation	23
A review of biosensor technology and algorithms for glucose monitoring	23
The association of smoking status with glycemic control, metabolic profile and diabetic complications– Results of the Australian National Diabetes Audit (ANDA)	22
Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality	22
Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis	22
Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease	22
Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring	21
Role of aromatic amino acids in pathogeneses of diabetic nephropathy in Chinese patients with type 2 diabetes	21
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis	20
Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease	19
Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data	19
A new look at brittle diabetes	18
Monogenic and syndromic diabetes due to endoplasmic reticulum stress	18
Toward a more comprehensive understanding of the emotional side of type 2 diabetes: A re-envisioning of the assessment of diabetes distress	18
Economic burden of diabetes-related hypoglycemia on patients, payors, and employers	18
Burnout, distress, and depressive symptoms in adults with type 1 diabetes	18
Cardio-renal protection in older people with diabetes with frailty and medical comorbidities - A focus on the new hypoglycaemic therapy	18
LncRNA MEG8 is upregulated in gestational diabetes mellitus (GDM) and predicted kidney injury	18
Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark	17
Systemic inflammatory biomarkers in painful diabetic neuropathy	17
Renal sinus fat volume in type 2 diabetes mellitus is associated with glycated hemoglobin and metabolic risk factors	17
Strategies to educe severe diabetic foot nfections and complications uring pidemics (STRIDE)	17
Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes	16
Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China	16
Barriers to diabetic foot care in a disadvantaged population: A qualitative assessment	16
Autologous platelet-rich plasma treatment for patients with diabetic foot ulcers: a meta-analysis of randomized studies	16
Variation in the hemoglobin glycation index	16
Down-regulation of microRNA-30d-5p is associated with gestational diabetes mellitus by targeting RAB8A	16
Effectiveness of cognitive behavioral therapy-based interventions on psychological symptoms in adults with type 2 diabetes mellitus: An update review of randomized controlled trials	16
Glucagon use by U.S. adults with type 1 and type 2 diabetes	16
Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus	16
Estimating costs of diabetes complications in people <65 years in the U.S. using panel data	16
Effects of single bout resistance exercise on glucose levels, insulin action, and cardiovascular risk in type 2 diabetes: A narrative review	16
Type 2 diabetes mellitus metabolic control correlates with the phenotype of human monocytes and monocyte-derived macrophages	15
Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis	15
Circ-Klhl8 overexpression increased the therapeutic effect of EPCs in diabetic wound healing via the miR-212-3p/SIRT5 axis	14
Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: A retrospective cohort study	14
Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India	14
Pharmacological management of COVID-19 in type 2 diabetes	14
Association of periodontitis with microvascular complications of diabetes mellitus: A nationwide cohort study	14
The mediating and interacting role of physical activity and sedentary behavior between diabetes and depression in people with obesity in United States	14
The impact of sensory and/or sensorimotor neuropathy on lower limb muscle endurance, explosive and maximal muscle strength in patients with type 2 diabetes mellitus	13

Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes	13
A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus	13
Comparison of accuracy between flash glucose monitoring and continuous glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis	13
COVID-19-associated Mucormycosis: A clinico-epidemiological study	13
Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists	13
Cardiovascular disease in young People with Type 1 Diabetes: Search for Cardiovascular Biomarkers	13
Is HbA1c in the first trimester associated with adverse outcomes among pregnant Asian Indian women without gestational diabetes?	13
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases	12
Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review	12
Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease	12
Association of FTO, ABCA1, ADRB3, and PPARG variants with obesity, type 2 diabetes, and metabolic syndrome in a Northwest Mexican adult population	12
A new perspective on diabetes distress using the type 2 diabetes distress assessment system (T2-DDAS): Prevalence and change over time	12
Minor vs. major leg amputation in adults with diabetes: Six-month readmissions, reamputations, and complications	12
Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population	12
Monocyte phenotype as a predictive marker for wound healing in diabetes-related foot ulcers	12
“Hyperglycemia aversiveness”: Investigating an overlooked problem among adults with type 1 diabetes	12
Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformi	12
Amputation-free survival in patients with diabetic foot ulcer and peripheral arterial disease: Endovascular versus open surgery in a propensity score adjusted analysis	12
Higher extracellular water to total body water ratio was associated with chronic kidney disease progression in type 2 diabetes	12
SFDI biomarkers provide a quantitative ulcer risk metric and can be used to predict diabetic foot ulcer onset	11
Neurological manifestations in m.3243A>G-related disease triggered by metformin	11
Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease	11
Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10-year longitudinal cohort study	11
Weight-centric pharmacological management of type 2 diabetes mellitus – An essential component of cardiovascular disease prevention	11
Urologic complications in diabetes	11
Nativity and prevalence of cardiometabolic diseases among U.S. Asian immigrants	11
Global survey investigating causes of treatment inertia in type 2 diabetes cardiorenal risk management	11
Effects of increased physical activity and/or weight loss diet on serum myokine and adipokine levels in overweight adults with impaired glucose metabolism	11
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes	11
The conundrum of diabetic neuropathies—Past, present, and future	11
Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System cohort	11
Associations of diabetes self-management characteristics, HbA1c, and psychosocial outcomes with depressive symptoms in a contemporary sample of adolescents with type 1 diabetes	11
Subclinical lipohypertrophy——Easily ignored complications of insulin therapy	10
Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years	10
Epicardial adipose tissue is tightly associated with exercise intolerance in patients with type 2 diabetes mellitus with asymptomatic left ventricular structural and functional abnormalities	10
On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clinical needs	10
Incidence of hypertension among Asian Indians: 10 year follow up of the Chennai Urban Rural Epidemiology Study (CURES-153)	10
The influence of time in range on daily mood in adults with type 1 diabetes	10
Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects	10
Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review	10
In-shoe pressure thresholds for people with diabetes and neuropathy at risk of ulceration: A systematic review	10
COVID 19 in-hospital mortality, body mass index and obesity related conditions	10
Second-trimester maternal lipid profiles rather than glucose levels predict the occurrence of neonatal macrosomia regardless of glucose tolerance status: A matched cohort study in Beijing	10
Using adult stem cells to monitor endothelial dysfunction in diabetes mellitus	10
Effects of moderate-intensity resistance exercise on blood glucose and pregnancy outcome in patients with gestational diabetes mellitus: A randomized controlled trial	10
The changing features of serum adropin, copeptin, neprilysin and chitotriosidase which are associated with vascular endothelial function in type 2 diabetic retinopathy patients	10
Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes	10
Baseline omega-3 level is associated with nerve regeneration following 12-months of omega-3 nutrition therapy in patients with type 1 diabetes	10
Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank	10
Characteristics of the microbiota in the urine of women with type 2 diabetes	9
Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity	9
Cardiovascular risk factor progression in adolescents and young adults with youth-onset type 2 diabetes	9
Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a n	9
Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents	9
The impact of Medicaid expansion on access to care and preventive care for adults with diabetes and depression	9
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study	9
Association of age at diabetes complication diagnosis with age at natural menopause in women with type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study	9
Burden of diabetes and oral cancer in India	9
Consuming a ketogenic diet leads to altered hypoglycemic counter-regulation in mice	9
Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice	9
Cardiovascular risk and heart rate variability in young adults with type 2 diabetes and arterial stiffness: The SEARCH for Diabetes in Youth Study	9
Risk factors associated with postpartum impaired glucose regulation in women with previous gestational diabetes	9
Prevalence of restless legs syndrome and quality of sleep in type 2 diabetics	9
Association of depression and parasympathetic activation with glycemic control in type 2 diabetes mellitus	8
Insulin resistance-associated genetic variants in type 1 diabetes	8
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol	8
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries	8
Screening and identification of circulating miRNA molecular markers in T2DM based on molecular network	8
ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy	8
Effect of Oral CNSA-001 (sepiapterin, PTC923) on gastric accommodation in women with diabetic gastroparesis: A randomized, placebo-controlled, Phase 2 trial	8
Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease	8
Adiponectin predicts the antioxidant capacity and size of high-density lipoprotein (HDL) in individuals with diabetes mellitus	8
Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysis	8
Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines	8
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps	8
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease	8
Effects of sodium-glucose co-transporter 2 inhibitors on liver fibrosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: An updated meta-analysis of randomized controlled t	8
Amputation and infection are the greatest fears in patients with diabetes foot complications	8
Diabetes on sepsis outcomes in non-ICU patients: A cohort study and review of the literature	8
Diabetes subgroups and risk for complications: The Multi-Ethnic Study of Atherosclerosis (MESA)	8

Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study	8
Prevalence, determinants and prognostic value of high coronary artery calcium score in asymptomatic patients with diabetes: A systematic review and meta-analysis	8
Worries and concerns about hypoglycemia in adults with type 1 diabetes: An examination of the reliability and validity of the Hypoglycemic Attitudes and Behavior Scale (HABS)	8
The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors	7
Diabetes mellitus associated with an increased risk of percutaneous coronary intervention long-term adverse outcomes in Taiwan: A nationwide population-based cohort study	7
Evidence of dysregulated iron homeostasis in newly diagnosed diabetics, but not in pre-diabetics	7
Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery disease	7
Association of non-HDL-C/HDL-C ratio and its dynamic changes with incident type 2 diabetes mellitus: The Rural Chinese Cohort Study	7
Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetes	7
Peripheral, synaptic and central neuronal transmission is affected in type 1 diabetes	7
Awareness of hypoglycemia and spectral analysis of heart rate variability in type 1 diabetes	7
Urinary cathepsin L is predictive of changes in albuminuria and correlates with glucosepane in patients with type 2 diabetes in a closed-cohort study	7
Increased plasma miR-146a levels are associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus	7
A comparison of the ratios of C-reactive protein and triglycerides to high-density lipoprotein-cholesterol as biomarkers of metabolic syndrome in African Americans and non-Hispanic Whites	7
Influence of glucose, insulin fluctuation, and glycosylated hemoglobin on the outcome of sarcopenia in patients with type 2 diabetes mellitus	7
Effects of aldose reductase inhibitors on renal blood flow parameters in patients with early diabetic nephropathy	7
Young adult onset type 2 diabetes versus type 1 diabetes: Progression to and survival on renal replacement therapy	7
Association of matrix metalloproteinase-2 gene polymorphisms with susceptibility to type 2 diabetes: A case control study	7
Association between the antepartum oral glucose tolerance test and the risk of future diabetes mellitus among women with gestational diabetes: A systematic review and meta-analysis	7
Quantitative gait and postural analyses in patients with diabetic polyneuropathy	7
Hemoglobin glycation index in relationship to the risk of cardiovascular complication in patients with type 2 diabetes: A systematic review and meta-analysis	7
Sex-influenced association between free triiodothyronine levels and poor glycemic control in euthyroid patients with type 2 diabetes mellitus	7
Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population	7
Relationship between elevated microRNAs and growth factors levels in the vitreous of patients with proliferative diabetic retinopathy	7
Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes	7
Emotional burden and care of adults with type 1 diabetes during the COVID-19 pandemic in Brazilian regions	7
Bone mass and dietary intake in children and adolescents with type 1 diabetes mellitus	7
The influence of diabetes and prediabetes on left heart remodeling: A population-based study	7
Comparison of the risk of SGLT2is and NonSGLT2is in leading to amputation: A network meta-analysis	7
Altered RBC membrane lipidome: A possible etiopathogenic link for the microvascular impairment in Type 2 diabetes	7
Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus	7
Domains from the health belief model predict enrollment in the National Diabetes Prevention Program among insured adults with prediabetes	7